Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Ardelyx (ARDX)
NASDAQ:ARDX
Ardelyx (ARDX) Stock Price & Analysis
749 Followers
ARDX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.49 - $5.13
Previous Close$3.27
Volume4.48M
Average Volume (3M)7.50M
Market Cap
$701.29M
Enterprise Value$606.61M
Total Cash (Recent Filing)$130.37M
Total Debt (Recent Filing)$35.69M
Price to Earnings (P/E)-8.2
Beta0.61
Next Earnings
Aug 11, 2023EPS Estimate
-$0.11Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.40
Shares Outstanding214,462,429
10 Day Avg. Volume7,023,129
30 Day Avg. Volume7,503,468
Standard Deviation0.24
R-Squared0.07
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)6.25
Price to Sales (P/S)61.69
Price to Cash Flow (P/CF)-4.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue9.62
Enterprise Value/Gross Profit12.63
Enterprise Value/Ebitda-8.36
Forecast
1Y Price Target
$7.25Price Target Upside121.71% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
Ardelyx News
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ARDX FAQ
What was Ardelyx’s price range in the past 12 months?
Ardelyx lowest stock price was $0.49 and its highest was $5.13 in the past 12 months.
What is Ardelyx’s market cap?
Currently, no data Available
When is Ardelyx’s upcoming earnings report date?
Ardelyx’s upcoming earnings report date is Aug 11, 2023 which is in 75 days.
How were Ardelyx’s earnings last quarter?
Ardelyx released its earnings results on May 03, 2023. The company reported -$0.13 earnings per share for the quarter, missing the consensus estimate of -$0.101 by -$0.029.
Is Ardelyx overvalued?
According to Wall Street analysts Ardelyx’s price is currently Undervalued.
Does Ardelyx pay dividends?
Ardelyx does not currently pay dividends.
What is Ardelyx’s EPS estimate?
Ardelyx’s EPS estimate is -$0.11.
How many shares outstanding does Ardelyx have?
Ardelyx has 214,462,430 shares outstanding.
What happened to Ardelyx’s price movement after its last earnings report?
Ardelyx reported an EPS of -$0.13 in its last earnings report, missing expectations of -$0.101. Following the earnings report the stock price went up 0.427%.
Which hedge fund is a major shareholder of Ardelyx?
Among the largest hedge funds holding Ardelyx’s share is Woodline Partners LP. It holds Ardelyx’s shares valued at 5M.
---
Ardelyx Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$7.25 (121.71% Upside)
$7.25 (121.71% Upside)
Blogger Sentiment
Bullish
ARDX Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 2.6M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $40.9K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▼ 0.3%
Last 30 Days ▲ 0.9%
Last 30 Days ▲ 0.9%
News Sentiment
Neutral
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
431.70%
12-Months-Change
Fundamentals
Return on Equity
-69.52%
Trailing 12-Months
Asset Growth
67.70%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Ardelyx
Ardelyx, Inc. is a biopharmaceutical company, which engages in the research, development and commercialization of medicine for the treatment of renal diseases. It focuses on the formulation of programs directed toward treating gastrointestinal and irritable bowel syndrome with constipations. Its product portfolio includes tenapanor, which is an experimental medication that works exclusively in the gut and is in late-stage clinical development. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet on October 17, 2007 and is headquartered in Fremont, CA.
---
Top 5 ETFs holding ARDX
Invesco DWA Healthcare Momentum ETF
$3.80M
iShares NASDAQ US Biotechnology UCITS ETF
$348.55K
Fidelity MSCI Health Care Index ETF
$322.46K
Invesco Nasdaq Biotechnology ETF
$13.67K
Up to five ETFs with an Outperform Smart Score that hold ARDX. The ETFs are listed according to market value of ARDX within the ETF
---
---